Solomon Moshkevich - 12 Aug 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
PRESIDENT, CLINICALDIAGNOSTICS
Signature
/s/ Vincent Fontanilla, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
12 Aug 2025
Net transactions value
-$136,027
Form type
4
Filing time
15 Aug 2025, 21:35:06 UTC
Previous filing
05 Aug 2025
Next filing
05 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN /s/ Vincent Fontanilla, Attorney-in-Fact 15 Aug 2025 0002010019

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Award +1,675 +1.4% 124,734 12 Aug 2025 Direct F1, F2
transaction NTRA Common Stock Sale $134,784 -867 -0.7% $155.46 123,867 14 Aug 2025 Direct F3
transaction NTRA Common Stock Sale $1,243 -8 -0.01% $155.42 123,859 14 Aug 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On October 22, 2021, the Reporting Person was granted Restricted Stock Units ("RSUs") covering 10,000 shares of Common Stock which vest in tranches upon the achievement of certain milestones relating to a combination of the passage of time and certain business performance criteria. On August 12, 2025, the achievement of criteria was certified for the vesting of RSUs covering 1,675 shares of Common Stock.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on October 22, 2021.